Complications of grafts used in female pelvic floor reconstruction: Mesh erosion and extrusion.
BACKGROUND
Various grafts have been used in the treatment of urinary incontinence and pelvic prolapse. Autologous materials such as muscle and fascia were first utilized to provide additional anatomic support to the periurethral and pelvic tissues; however, attempts to minimize the invasiveness of the procedures have led to the use of synthetic materials. Complications such as infection and erosion or extrusion associated with these materials may be troublesome to manage. We review the literature and describe a brief overview of grafts used in pelvic floor reconstruction and focus on the management complications specifically related to synthetic materials.


METHODS
We performed a comprehensive review of the literature on grafts used in pelvic floor surgery using MEDLINE and resources cited in those peer-reviewed manuscripts. The results are presented.


RESULTS
Biologic materials provide adequate cure rates but have associated downfalls including potential complications from harvesting, variable tissue quality and cost. The use of synthetic materials as an alternative graft in pelvic floor repairs has become a popular option. Of all synthetic materials, the type I macroporous polypropylene meshes have demonstrated superiority in terms of efficacy and fewer complication rates due to their structure and composition. Erosion and extrusion of mesh are common and troublesome complications that may be managed conservatively with observation with or without local hormone therapy, with transvaginal debridement or with surgical exploration and total mesh excision, dependent upon the location of the mesh and the mesh type utilized.


CONCLUSIONS
The ideal graft would provide structural integrity and durability with minimal adverse reaction by the host tissue. Biologic materials in general tend to have fewer associated complications, however, the risks of harvesting, variable integrity of allografts, availability and high cost has led to the development and use of synthetic grafts. Synthetic grafts have a tendency to cause higher rates of erosion and extrusion; however, these complications can be managed successfully.
Nazemi
Tanya M
TM
Continence Center at Virginia Mason Medical Center, Seattle, Washington, USA.
Kobashi
Kathleen C
KC
Am J Obstet Gynecol. 2005 May;192(5):1496-500
15902148
Urology. 2005 Sep;66(3):469-75
16140060
Obstet Gynecol. 1995 Jul;86(1):92-6
7784030
Am J Obstet Gynecol. 2005 Jun;192(6):1956-62
15970860
BJU Int. 2005 Jul;96(1):103-6
15963130
BJU Int. 2006 Jan;97(1):201-10
16336363
Int Urogynecol J Pelvic Floor Dysfunct. 2006 Jun;17(4):315-20
16228121
Obstet Gynecol. 2006 Feb;107(2 Pt 2):472-4
16449154
Int Urogynecol J Pelvic Floor Dysfunct. 2005 Nov-Dec;16(6):506-8
15645145
BJU Int. 2004 Jul;94(1):110-3
15217442
J Urol. 2006 Aug;176(2):651-4; discussion 654
16813914
Eur J Obstet Gynecol Reprod Biol. 2006 Jul;127(1):123-9
16384631
J Urol. 2003 Jul;170(1):134-7; discussion 137
12796665
Curr Opin Urol. 2006 Mar;16(2):54-9
16479204
Obstet Gynecol. 1998 Dec;92(6):999-1004
9840566
Int Urogynecol J Pelvic Floor Dysfunct. 2003 Feb;14(1):17-23; discussion 21-2
12601511
Curr Opin Obstet Gynecol. 2006 Oct;18(5):560-6
16932053
Int Urogynecol J Pelvic Floor Dysfunct. 2005 Sep-Oct;16(5):389-94
15657636
J Urol. 2000 Jun;163(6):1835-7
10799193
Eur Urol. 2004 Nov;46(5):629-35
15474274
Int Urogynecol J Pelvic Floor Dysfunct. 2005 Nov-Dec;16(6):509-11
15735894
Int Urogynecol J Pelvic Floor Dysfunct. 2005 Sep-Oct;16(5):375-7
15647884
Urology. 2003 Nov;62(5):805-9
14624898
Am J Obstet Gynecol. 2006 May;194(5):1444-9
16579930
Urology. 2005 Nov;66(5):995-9
16286110
Curr Opin Obstet Gynecol. 2005 Oct;17(5):519-29
16141767
Am J Obstet Gynecol. 2003 Dec;189(6):1612-8; discussion 1618-9
14710083
J Urol. 2003 Jun;169(6):2242-3
12771759
Curr Opin Urol. 2004 Nov;14(6):317-21
15626872
Int J Urol. 2001 Dec;8(12):675-80
11851767
JSLS. 2006 Apr-Jun;10(2):220-5
16882424
Urology. 2000 Oct 1;56(4):589-94
11018611
J Urol. 2006 May;175(5):1788-92; discussion 1793
16600762
J Urol. 2003 May;169(5):1662-9
12686804
J Urol. 2005 May;173(5):1627-30
15821518
BJU Int. 2006 Aug;98(2):367-76
16879679
Int Urogynecol J Pelvic Floor Dysfunct. 2005 Nov-Dec;16(6):437-40
15654499
J Urol. 1999 Dec;162(6):2070-2
10569572
Urology. 2000 Dec 4;56(6 Suppl 1):2-8
11114556
Am J Obstet Gynecol. 2001 Jul;185(1):32-40
11483900
Urology. 2004 Jun;63(6):1066-70
15183951
Obstet Gynecol. 2004 May;103(5 Pt 2):1040-2
15121600
J Urol. 1997 Sep;158(3 Pt 1):875-80
9258103
J Urol. 2005 Oct;174(4 Pt 1):1308-11
16145409
J Urol. 2005 Apr;173(4):1229-33
15758758
Urology. 1999 Oct;54(4):641-6
10510921
J Urol. 2004 Jan;171(1):268-71
14665891
Obstet Gynecol. 2004 Oct;104(4):805-23
15458906
J Urol. 2004 Apr;171(4):1581-4
15017225
J Urol. 1998 Sep;160(3 Pt 1):759-62
9720541
Langenbecks Arch Chir. 1994;379(3):168-71
8052058